Tech Defeat Everything Years: Jury Faces Big Tech Liability
A California jury confronts a high-stakes question: can the way social apps are built cause harm to young users? The ...
Why Active Funds May Underperform Benchmarks
Why Active Funds May Underperform Benchmarks discusses persistent headwinds, costs, and timing issues that hinder outperformance.
26,804 articles
The $10,000 Loan Deduction: Here's Who Qualifies Now
A new car loan interest deduction could trim tax bills for buyers of eligible U.S.-assembled vehicles. Here’s who qua...
XRP Price Analysis: Should Your Losses Be Cut or Held?
XRP trades near $1.42 after a volatile week that left many investors debating whether to cut losses or hold for a reb...
Working Past $6,000 Senior: Phase-Out Penalties Hit Retirees
A new $6,000 senior tax deduction comes with an income-based phase-out that can trim or erase relief for those who wo...
Did Amazon Just Deliver Sweeping Moves Against IonQ
A quiet stake in IonQ has sparked big questions. Is Amazon signaling a sweeping strategic shift in quantum computing,...
Zscaler Stock After Share: Is It a Buy After the Slump?
When a cybersecurity stock slides, it tests your risk tolerance and judgment. This guide breaks down what happened wi...
Dividend Safety Check: SNPD and Dividend Stalwarts
SNPD targets 60+ year dividend growers to deliver steady income. This report examines whether its payout remains dura...
JPMorgan: 2026 Rally Entirely Earnings-Driven Gains Ground
A JPMorgan Private Bank view argues that the 2026 rally is driven by earnings strength, with a base-case S&P 500 arou...
66-Year-Old 50/50 From Advisor Sparks Retirement Debate
Two financial plans, one patient retiree, and a surprising reframe: treating Social Security as a bond changes how a ...
Investors Eye Microsoft’s Lays Next Massive AI Trade
Microsoft’s Satya Nadella signals a data-centric AI strategy, arguing buyers must reveal proprietary know-how to unlo...
How to Consolidate Student Loans Effectively in 2026
New consolidation options are rolling out in 2026 as rates hold steady. Borrowers weigh relief from payments against ...
Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status